Found First-Month vs Refill: Long-Term Compounded GLP-1 Treatment

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found does not use a first-month discount model. The $169/month semaglutide figure advertised on Found's website is the effective monthly rate of a 12-month prepaid cash plan that requires $2,028 upfront, billed every 48 weeks. The ongoing month-to-month rate for compounded semaglutide is $289 per four-week period—13 billing cycles per year—which works out to $313.08/month over twelve months. Found's insurance track follows the same structure: the advertised $99/month rate requires a $1,188 annual prepayment; the monthly insurance plan is $199 per period plus typical copays of around $30 per visit. Patients considering Found should budget for either the higher recurring monthly rate or the full upfront cost of the annual plan. PlexusDx offers compounded semaglutide injection at $189/month month-to-month or $169/month on a three-month commitment—the same effective rate as Found's annual plan, but without the $2,028 upfront requirement.

At-a-glance: Found pricing structure vs PlexusDx

Found pricing verified 2026-09-04 and 2026-07-20; PlexusDx pricing verified 2026-07-20.

Why Found's advertised rate isn't a first-month price

Found's marketing emphasizes "$169/mo for semaglutide" and "$239/mo for tirzepatide" on its cash-pay track. These figures are not introductory or promotional first-month rates; they are the effective monthly cost of a 12-month prepaid plan. To access the $169 semaglutide rate, a patient must pay $2,028 upfront, billed every 48 weeks. The tirzepatide equivalent requires an annual commitment at $239/month effective (total annual cost approximately $2,868, our calculation).

Patients who choose not to prepay an entire year will be billed at Found's month-to-month rate: $289 per four-week period for semaglutide and $359 per four-week period for tirzepatide. Because Found bills every four weeks rather than by calendar month, there are 13 billing cycles per year. Over twelve months, the $289 semaglutide plan costs $3,757 (our calculation: $289 × 13), or an effective $313.08 per month. The tirzepatide month-to-month plan totals $4,667 annually ($359 × 13), or $388.92 per month.

The practical implication: a patient budgeting month-to-month will pay $1,729 more per year for semaglutide and $1,799 more per year for tirzepatide than a patient who commits to the full-year prepaid plan. There is no discount that applies to the first month and then disappears; the cost structure is determined entirely by commitment length and upfront payment.

Found's insurance track: same prepaid vs monthly dynamic

Found offers an insurance track for patients whose plans cover compounded GLP-1 medications. The advertised rate is $99/month effective, based on a 12-month prepaid insurance plan that requires $1,188 upfront. The monthly insurance plan, by contrast, is $199 per four-week period—$2,388 over twelve months, or an effective $199/month before accounting for visit copays.

Insurance-track patients typically incur copays for live video visits with board-certified clinicians; a typical copay is around $30 per visit. Assuming four visits per year (quarterly check-ins), the annual cost of the monthly insurance plan becomes approximately $2,508 (base plan $2,388 plus $120 in copays), or about $209/month. The 12-month prepaid insurance plan totals approximately $1,308 annually (upfront $1,188 plus estimated $120 in copays), or roughly $109/month—a savings of $1,200 per year compared to the monthly insurance plan.

As with the cash track, the $99 figure is not a first-month rate; it is the result of paying for a full year in advance. Patients who prefer monthly flexibility will pay the $199 per-period rate plus applicable copays.

Normalized 12-month cost comparison: Found vs PlexusDx

To make a fair comparison between Found's prepaid and month-to-month structures and PlexusDx's transparent calendar-month pricing, we normalize all figures to a 12-month treatment period.

Compounded semaglutide injection

All multi-period calculations and effective monthly rates are our calculation based on verified per-period charges and billing cadence.

Compounded tirzepatide injection

Key takeaway: PlexusDx's month-to-month semaglutide plan ($2,268/year) costs $1,489 less annually than Found's month-to-month plan. PlexusDx's three-month semaglutide rate ($169/month, $2,028/year) matches Found's 12-month prepaid rate but requires only a three-month commitment rather than paying the full year upfront. For tirzepatide, PlexusDx's month-to-month plan saves $1,199 annually compared to Found's month-to-month rate, and PlexusDx's six-month commitment ($2,988/year) is $120 more per year than Found's 12-month prepaid rate but offers greater flexibility.

What Found includes beyond medication

Found's cash-pay and insurance plans include access to the Found app, 24/7 availability of the care team, an AI health companion called Aimee, and a supportive member community. Insurance-track patients receive live video visits with board-certified Found clinicians; cash-pay patients typically interact with their care team via text-based messaging. Found is in-network for approximately one in three Americans, and both tracks are HSA/FSA eligible.

Patients on Found's cash-pay track receive compounded semaglutide or tirzepatide as part of their flat monthly or prepaid rate. Patients on the insurance track have their compounded GLP-1 medication included in the base plan fee, but branded medications (Ozempic, Wegovy, Mounjaro, Zepbound) are billed separately through insurance. Found also offers Foundayo, an oral GLP-1 option, though pricing and availability details were not documented in the research packet.

PlexusDx plans include the prescribing visit, compounded medication, shipping, and an optional free Doctor of Pharmacy check-in. PlexusDx does not charge a separate membership fee, and the same monthly price applies at every dose level. An optional add-on testing for genetic variations that influence medication response is available for $298 ($99 for program members). PlexusDx operates cash-only and does not bill insurance.

Billing cadence matters: 13 charges vs 12 charges per year

One subtle but material difference between Found and PlexusDx is billing frequency. Found bills its month-to-month plans every four weeks, which yields 13 billing cycles per year (52 weeks ÷ 4). PlexusDx bills by calendar month, resulting in 12 charges per year.

For Found's month-to-month semaglutide plan, this means 13 charges of $289, totaling $3,757 annually—not the $3,468 that would result from 12 monthly charges. The extra billing cycle adds $289 to the annual cost. Patients accustomed to thinking in terms of "monthly subscriptions" may not immediately recognize that a per-period charge billed every four weeks will appear 13 times in a calendar year.

PlexusDx's calendar-month billing aligns with how most people budget. A $189/month charge appears exactly 12 times per year, for a total of $2,268. This straightforward cadence eliminates the surprise of a 13th charge and simplifies year-over-year cost planning.

When Found's prepaid plan makes sense

Found's 12-month prepaid cash plan offers a competitive effective monthly rate—$169 for semaglutide, $239 for tirzepatide—if you can and want to pay the full year upfront. For a patient confident in long-term commitment, comfortable with the upfront outlay, and drawn to Found's app-based coaching and community features, the prepaid plan delivers meaningful annual savings compared to Found's own month-to-month rate.

The 12-month prepaid insurance plan ($99/month effective, $1,188 upfront plus copays) similarly rewards patients who can commit and pay a year in advance. If your insurance covers compounded GLP-1s and you value live video visits with board-certified clinicians, Found's insurance track may be worth evaluating—provided you confirm your plan's coverage and copay structure before enrolling.

Found holds a 4.1-star rating on Trustpilot with approximately 732 reviews (captured September 4, 2026). The platform's 24/7 care-team access and Aimee AI companion may appeal to patients who want on-demand support and community engagement as part of their weight management journey.

When PlexusDx's flexible monthly pricing makes sense

PlexusDx offers the same $169/month effective rate as Found's annual semaglutide plan—but on a three-month commitment rather than a 12-month upfront payment. The three-month semaglutide plan costs $507 every three months ($169 × 3), for an annual total of $2,028. A patient unwilling or unable to pay $2,028 upfront can access the same per-month cost by committing to just one quarter at a time.

PlexusDx's six-month semaglutide rate ($149/month, $1,788/year) is $240 less annually than Found's 12-month prepaid plan and requires half the upfront commitment. For tirzepatide, PlexusDx's six-month rate ($249/month, $2,988/year) is slightly higher than Found's 12-month prepaid equivalent but still offers mid-length commitment flexibility.

PlexusDx's month-to-month plans carry no commitment at all. The month-to-month semaglutide rate is $189/month and the tirzepatide rate is $289/month, billed by calendar month (12 charges/year), and patients can pause or cancel without penalty. For patients prioritizing financial flexibility, testing medication tolerance before committing, or uncertain about long-term treatment duration, PlexusDx's month-to-month structure reduces risk.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). The same monthly price applies at every dose, and there are no membership fees or charges beyond the medication and prescribing visit.

Choose Found if…

• You are confident in a 12-month commitment and have the cash or budget to pay $2,028 (semaglutide) or approximately $2,868 (tirzepatide) upfront for a full year.
• You value app-based coaching, an AI health companion, and a member community as integrated parts of your treatment experience.
• You have insurance coverage for compounded GLP-1 medications and prefer live video visits with board-certified clinicians; confirm your plan's coverage and copay structure before enrollment.
• The 13-billing-cycle-per-year cadence is acceptable to you, and you understand the annual cost implications of four-week billing periods.

Choose PlexusDx if…

• You want the same $169/month semaglutide effective rate as Found's annual plan but prefer a three-month commitment ($507 upfront) over a 12-month payment.
• You prioritize month-to-month flexibility with no long-term commitment; PlexusDx semaglutide is $189/month month-to-month with 12 calendar-month billing cycles per year.
• You want a lower annual cost: PlexusDx's six-month semaglutide plan ($1,788/year) is $240 less than Found's 12-month prepaid plan; the month-to-month semaglutide plan ($2,268/year) is $1,489 less than Found's month-to-month rate.
• You prefer transparent, predictable calendar-month billing over four-week cycles and want to avoid the surprise of a 13th annual charge.
• You do not need or want app-based coaching, AI companion features, or community forums; you are comfortable with a streamlined medication-focused service that includes a Doctor of Pharmacy check-in and prescribing visit.

Methodology and freshness

All Found pricing figures in this article were verified from Found's public pricing page (captured September 11, 2026) and cross-checked against PlexusDx's internal competitive research dataset (captured September 4, 2026) and a PlexusDx comparison page last verified July 20, 2026. Found's month-to-month rates, prepaid plan structures, and billing cadence were confirmed across all three sources with no material conflicts.

Twelve-month cost calculations—including effective monthly rates for Found's four-week billing cycles and prepaid plans—are our calculation, derived from the documented per-period charges, billing frequency, and commitment length. We applied standard arithmetic: annual cost = per-period charge × periods per year; effective monthly cost = annual cost ÷ 12. Found's 3-month and 6-month plan figures were calculated using the verified per-month rates and the documented billing frequencies (every 12 weeks and every 24 weeks, respectively).

PlexusDx pricing and inclusions were verified from the same July 20, 2026 source and reflect current published rates. Trustpilot ratings for Found (4.1 stars, ~732 reviews) were captured September 4, 2026; Trustpilot ratings for PlexusDx (4.3 stars) were captured September 9, 2026 from trustpilot.com/review/plexusdx.com.

Insurance-track copay estimates ($30 per visit, four visits per year) are illustrative assumptions used to demonstrate the total cost of the insurance plan; actual copays and visit frequency vary by individual insurance plan and clinical need. Patients should confirm copay amounts and coverage details with their insurer before enrolling in Found's insurance track.

Frequently Asked Questions

Is Found's $169/month semaglutide rate a first-month promotional price?

No. The $169/month figure is the effective monthly cost of a 12-month prepaid cash plan that requires $2,028 upfront, billed every 48 weeks. It is not a temporary discount or introductory rate; it applies for the duration of the annual commitment. Found's ongoing month-to-month rate for semaglutide is $289 per four-week period.

How many times per year will I be charged on Found's month-to-month plan?

Found bills its month-to-month plans every four weeks, which results in 13 billing cycles per year (52 weeks ÷ 4 = 13). A $289 per-period charge becomes $3,757 annually for semaglutide. PlexusDx bills by calendar month (12 charges per year), so a $189/month charge totals $2,268 annually.

Can I access Found's $169 semaglutide rate without paying for a full year upfront?

No. Found's $169/month effective rate is only available on the 12-month prepaid plan, which requires $2,028 upfront. Found does offer 3-month ($249/month) and 6-month ($219/month) plans with lower upfront commitments, but neither reaches the $169 rate. PlexusDx offers a $169/month semaglutide rate on a three-month commitment ($507 upfront).

Does Found's insurance track include medication in the base price?

Yes, compounded GLP-1 medications (semaglutide, tirzepatide) are included in Found's insurance-track base plan price ($99/month effective on the 12-month prepaid plan, $199/month on the monthly plan). Branded medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are billed separately through your insurance. Live video visits typically require copays (around $30 per visit).

What is the total cost difference between Found and PlexusDx for semaglutide over one year on a flexible month-to-month plan?

Found's month-to-month semaglutide plan costs $3,757 over twelve months ($289 per four-week period × 13 cycles). PlexusDx's month-to-month semaglutide plan costs $2,268 over twelve months ($189/month × 12 months). PlexusDx saves $1,489 annually on a month-to-month basis, with no long-term commitment required.

Sources

• Found pricing page, verified July 20, 2026 and September 11, 2026 (internal PlexusDx comparison research)
• PlexusDx competitive research dataset, captured September 4, 2026 at 13:49:55 UTC
• PlexusDx product pages and inclusions, verified July 17–23, 2026
• Trustpilot reviews for Found, captured September 4, 2026
• Trustpilot reviews for PlexusDx (trustpilot.com/review/plexusdx.com), captured September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.